Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07159204 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

Study acronym: PILOT-BTC
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2026 (before its estimated August 12, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 7 months later Dec 31, 2025 → Aug 12, 2026
Primary endpoint removed 2 → 1 primary endpoints
Enrollment reduced 39% 100 → 61 participants
See other at-risk trials from Peking Union Medical College Hospital

Record History

  1. Primary completion pushed from Dec 31, 2025 to Aug 12, 2026 Primary endpoint(s) modified · Enrollment reduced: 100 → 61 participants · Start date: Jan 1, 2023 to Aug 7, 2024 · 6 morev2 Show 9 more changesShow less
    • Primary endpoint(s) modified
    • Enrollment reduced: 100 → 61 participants
    • Start date: Jan 1, 2023 to Aug 7, 2024
    • Enrollment closed, study ongoing
    • Completion pushed from Jul 1, 2026 to Dec 7, 2027
    • Eligibility criteria shortened, about 256 words
    • Secondary endpoints expanded, about 12 words
    • Site details revised
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen
Trial Details
NCT Number NCT07159204
Lead Sponsor Peking Union Medical College Hospital
Conditions Biliary Tract Cancer (BTC)
Enrollment 61 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov